Literature DB >> 15546274

Pharmacoeconomics: the cost of prophylactic migraine treatments.

Leon C Adelman1, James U Adelman, Marshall C Freeman, Randal L Von Seggern.   

Abstract

Migraine preventive medications considered effective reduce headache frequency by 50 percent in approximately 50 percent of treated patients. In spite of similar effectiveness, these medications vary tremendonsly in their prices. Knowledge of medication prices and employing cost-effective strategies may greatly reduce treatment costs.

Entities:  

Mesh:

Year:  2004        PMID: 15546274     DOI: 10.1111/j.1526-4610.2004.4200_4.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  3 in total

1.  Direct costs of preventive headache treatments: comparison of behavioral and pharmacologic approaches.

Authors:  Allison M Schafer; Jeanetta C Rains; Donald B Penzien; Leanne Groban; Todd A Smitherman; Timothy T Houle
Journal:  Headache       Date:  2011-06       Impact factor: 5.887

Review 2.  The effect of migraine prophylaxis on migraine-related resource use and productivity.

Authors:  Miguel J A Láinez
Journal:  CNS Drugs       Date:  2009-09       Impact factor: 5.749

3.  Prophylaxis of migraine.

Authors:  Ivan Garza; Jerry W Swanson
Journal:  Neuropsychiatr Dis Treat       Date:  2006-09       Impact factor: 2.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.